Read Time:9 Second
The Federal Trade Commission is looking to speed up its inquiry into prescription-drug middlemen while also expanding its scrutiny of drug patents, FTC Chair Lina Khan said Tuesday.
Happy
0 %
Sad
0 %
Excited
0 %
Sleepy
0 %
Angry
0 %
Surprise
0 %
0
0
Average Rating